Psychosomatics
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Psychosomatics 46:508-516, December 2005
doi: 10.1176/appi.psy.46.6.508
© 2005 Academy of Psychosomatic Medicine
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Schillerstrom, J. E.
* Articles by Royall, D. R.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Schillerstrom, J. E.
* Articles by Royall, D. R.
Related Collections
* Informed Consent
* AIDS/HIV
* Stroke
* Syndromes Secondary to General Medical Disorders

Review

The Impact of Medical Illness on Executive Function

Jason E. Schillerstrom, M.D., Monica S. Horton, M.D., and Donald R. Royall, M.D.

Received Aug. 2, 2004; revision received Nov. 30, 2004; accepted Dec. 16, 2004. From the Departments of Psychiatry, Medicine, and Pharmacology, University of Texas Health Science Center at San Antonio; and the Geriatric Research Education and Clinical Center, Audie L. Murphy Division, South Texas Veterans Health Administration. Address correspondence and reprint requests to Dr. Schillerstrom, Department of Psychiatry, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., San Antonio, TX 78229; schillerstr{at}uthscsa.edu (e-mail).

Executive function can be defined as one’s ability to plan, initiate, sequence, monitor, and inhibit complex goal-directed behaviors. Although executive impairment is generally associated with dementia, recent studies have suggested that patients with chronic diseases, such as hypertension, chronic obstructive pulmonary disease, and diabetes, may also have executive deficits independent of psychiatric comorbidities. Because executive function is associated with functional outcomes, medication compliance, and the capacity to give informed consent, it is important that it be assessed. However, it is the authors’ impression that executive function is not adequately assessed in medical settings, despite the availability of reliable measures. This article reviews the impact of medical illness on executive function and discusses practical diagnostic instruments and treatment strategies. The changes in functional status associated with executive impairment as well as pathophysiology and treatment strategies are also discussed.




This article has been cited by other articles:


Home page
Ann. N. Y. Acad. Sci.Home page
A. SANDBERG and N. BOSTROM
Converging Cognitive Enhancements
Ann. N.Y. Acad. Sci., December 1, 2006; 1093(1): 201 - 227.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2005 Academy of Psychosomatic Medicine. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. Academy of Psychosomatic Medicine
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org